A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease
Crossref DOI link: https://doi.org/10.1007/s12031-016-0810-z
Published Online: 2016-08-11
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buckley, Rachel F.
Villemagne, Victor L.
Masters, Colin L.
Ellis, Kathryn A.
Rowe, Christopher C.
Johnson, Keith
Sperling, Reisa
Amariglio, Rebecca
Funding for this research was provided by:
National Health and Medical Research Council (1105576)
License valid from 2016-08-11